In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.



Where Data Shapes the Future of Heart Care 


The mission of EuroHeart is to improve cardiovascular care by monitoring high-quality harmonised patient data at hospital admission and over time. This approach can provide healthcare professionals with real-time insights, advancing the standard of care and driving better patient outcomes.
EuroHeart has released its inaugural annual report, presenting 2022 data on acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) from seven countries. Covering nearly 40,000 patients, this report represents a significant milestone in EuroHeart's mission to advance cardiovascular care. Read the report.



euroheart-logo.jpgEuroHeart is an ESC initiative based on a collaboration between national registries and in collaboration with national cardiac societies. The aim of national registries is to continually monitor quality of care at national and local levels as a necessary prerequisite to improving care effectively. EuroHeart is predominantly designed for the benefit of patients, citizens and the planning of healthcare investments.

The EuroHeart initiative

In July 2019, the ESC Board approved the launch of a two-year pilot phase of EuroHeart, involving two to four countries, to assess the feasibility of implementation of EuroHeart in different healthcare systems. In October 2022, the ESC Board approved the next project phase - the consolidation phase - with the purpose of continuing to maintain and expand the network of collaborating countries. The consolidation phase ends in December 2024.

ESC concluded that there is a need to:

  • further develop ESC-generated observational data
  • expand the scope of the registry programme to include
    • direct quality development
    • device monitoring
    • registry based randomised trials

Key features

  • Is based on the development of and collaboration between national programmes that use common data sets and quality criteria.
  • Will include representatives from the participating countries in the development and in all subcommittees.
  • Supports continuous development of quality of care based on individual patient data.
  • Starts with the development of standardised data sets and quality indicators for common disease areas ACS-PCI, heart failure, atrial fibrillation and valve disease.
  • Will develop a Data Science Center for collaborative research efforts on data in agreement with the involved countries and their national/local registries.   
  • Provides an optional Registry IT platform with possibilities to develop integrated tools for device surveillance and registry-based randomised clinical trials (R-RCT).

EuroHeart Executive Committee

Co-Chairs: Prof. Barbara Casadei and Prof. Lars Wallentin

Members: Jean-François Riffaud, Prof. Chris P Gale, Prof. Aldo Maggioni, Sara Hansson
Project manager: Ebba Bergman


For more details about the EuroHeart project, Data standards, EuroHeart Registry IT platform and its development, or if you would like your country to participate in the EuroHeart project, please contact us by email.